Hypersensitivity to the active substance or to any of the excipients:


Sodium chloride

Sodium dihydrogen phosphate monohydrate

Disodium hydrogen phosphate heptahydrate

Water for injections


Sepsis or risk of sepsis.


Treatment with Benepali should not be initiated in patients with active infections, including chronic or localised infections.


See the full Summary of Product Characteristics for further information.